BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Scribano ML, Prantera C. Use of antibiotics in the treatment of Crohn’s disease. World J Gastroenterol 2013; 19(5): 648-653 [PMID: 23429474 DOI: 10.3748/wjg.v19.i5.648]
URL: https://www.wjgnet.com/1007-9327/full/v19/i5/648.htm
Number Citing Articles
1
Saeed Shakibfar, Kristine Allin, Tine Jess, Maria Antonietta Barbieri, Vera Battini, Eva Simoncic, Julien Kirchgesner, Trond Ulven, Maurizio Sessa. Drug Repurposing in Crohn’s Disease Using Danish Real-World DataPragmatic and Observational Research 2024; : 17 doi: 10.2147/POR.S444569
2
Cristina Rosário. Infection and Autoimmunity2015; : 279 doi: 10.1016/B978-0-444-63269-2.00008-8
3
Emma Slack, Maria L. Balmer, Andrew J. Macpherson. B cells as a critical node in the microbiota–host immune system network Immunological Reviews 2014; 260(1): 50 doi: 10.1111/imr.12179
4
Franz Hartmann. Durchfälle und Bauchschmerzen – was steckt dahinter?MMW - Fortschritte der Medizin 2013; 155(25): 57 doi: 10.1007/s15006-013-2128-x
5
Herbert L. DuPont. Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal DiseasesMayo Clinic Proceedings 2015; 90(8): 1116 doi: 10.1016/j.mayocp.2015.04.016
6
R. B. Sartor. Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseasesAlimentary Pharmacology & Therapeutics 2016; 43(S1): 27 doi: 10.1111/apt.13436
7
Morris Gordon, Vassiliki Sinopoulou, Ciaran Grafton-Clarke, Anthony K Akobeng. Antibiotics for the induction and maintenance of remission in ulcerative colitisCochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD013743.pub2
8
Neil D. Goldberg, Aravinda Vadlamudi, Nicole Parrish. Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and MetronidazoleCase Reports in Gastroenterology 2015; 9(1): 25 doi: 10.1159/000369965
9
Anna Wajda, Larysa Sivitskaya, Agnieszka Paradowska-Gorycka. Application of NGS Technology in Understanding the Pathology of Autoimmune DiseasesJournal of Clinical Medicine 2021; 10(15): 3334 doi: 10.3390/jcm10153334
10
Cassandra M Townsend, Claire E Parker, John K MacDonald, Tran M Nguyen, Vipul Jairath, Brian G Feagan, Reena Khanna. Antibiotics for induction and maintenance of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD012730.pub2
11
Morris Gordon, Ciaran Grafton-Clarke, Vassiliki Sinopoulou, Anthony K Akobeng. Antibiotics for the induction and maintenance of remission in ulcerative colitisCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013743
12
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut 2019; 68(Suppl 3): s1 doi: 10.1136/gutjnl-2019-318484
13
Loris R. Lopetuso, Marco Napoli, Gianenrico Rizzatti, Antonio Gasbarrini. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s diseaseExpert Opinion on Investigational Drugs 2018; 27(6): 543 doi: 10.1080/13543784.2018.1483333
14
Daya K. Jha, Shubhra Mishra, Usha Dutta, Vishal Sharma. Antibiotics for inflammatory bowel disease: Current statusIndian Journal of Gastroenterology 2024; 43(1): 145 doi: 10.1007/s12664-024-01537-x
15
Aditi Kumar, Hafid O. Al-Hassi, Helen Steed, Oliver Phipps, Matthew J. Brookes, Masanao Nakamura. Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn’s DiseaseCanadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/8416578
16
Scott A. Strong. The ASCRS Textbook of Colon and Rectal Surgery2016; : 807 doi: 10.1007/978-3-319-25970-3_47
17
Shuo Yuan, Ke-Si Wang, Huan Meng, Xiao-Ting Hou, Jia-Chen Xue, Bao-Hong Liu, Wen-Wen Cheng, Jiao Li, Hua-Min Zhang, Ji-Xing Nan, Qing-Gao Zhang. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapyBiomedicine & Pharmacotherapy 2023; 165: 114893 doi: 10.1016/j.biopha.2023.114893
18
Adeline Sivignon, Julie Bouckaert, Julien Bernard, Sebastien G. Gouin, Nicolas Barnich. The potential of FimH as a novel therapeutic target for the treatment of Crohn’s diseaseExpert Opinion on Therapeutic Targets 2017; 21(9): 837 doi: 10.1080/14728222.2017.1363184
19
Maria Lia Scribano, Cosimo Prantera. Antibiotics and Inflammatory Bowel DiseasesDigestive Diseases 2013; 31(3-4): 379 doi: 10.1159/000354704
20
Daniel Sprockett, Natalie Fischer, Rotem Sigall Boneh, Dan Turner, Jarek Kierkus, Malgorzata Sladek, Johanna C Escher, Eytan Wine, Baruch Yerushalmi, Jorge Amil Dias, Ron Shaoul, Michal Kori, Scott B Snapper, Susan Holmes, Athos Bousvaros, Arie Levine, David A Relman. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn’s Disease CohortInflammatory Bowel Diseases 2019; 25(12): 1927 doi: 10.1093/ibd/izz130
21
Sushila R. Dalal, Eugene B. Chang. The microbial basis of inflammatory bowel diseasesJournal of Clinical Investigation 2014; 124(10): 4190 doi: 10.1172/JCI72330
22
Peter Girgis, Tanisha LNU, Amna Ahmad, Mina Daniel, Maria Kamel, Jade L Gambill, Atika Shahzadi, Usman Khan, Anam Zara, Vagisha Sharma. Advancements in Targeted Therapies for the Management of Crohn’s Disease: A Comprehensive ReviewCureus 2024;  doi: 10.7759/cureus.61751
23
Allison Agus, Sébastien Massier, Arlette Darfeuille-Michaud, Elisabeth Billard, Nicolas Barnich. Understanding Host-Adherent-InvasiveEscherichia coliInteraction in Crohn’s Disease: Opening Up New Therapeutic StrategiesBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/567929
24
Cristina Rosário, Rita Noversa de Sousa. Infection and Autoimmunity2024; : 407 doi: 10.1016/B978-0-323-99130-8.00006-4
25
Mario Matijašić, Tomislav Meštrović, Mihaela Perić, Hana Čipčić Paljetak, Marina Panek, Darija Vranešić Bender, Dina Ljubas Kelečić, Željko Krznarić, Donatella Verbanac. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsInternational Journal of Molecular Sciences 2016; 17(4): 578 doi: 10.3390/ijms17040578
26
Cassandra M Townsend, Claire E Parker, John K MacDonald, Vipul Jairath, Brian G Feagan, Reena Khanna. Antibiotics for induction and maintenance of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD012730